SHREE HARI INTL
GenericsSHREE HARI INTL is a generic drug manufacturer focused on Immunology.
SHREE HARI INTL's Key Drugs
SHREE HARI INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SHREE HARI INTL's Recent FDA Approvals
New NDA/BLA approvals for SHREE HARI INTL over the last two years — novel drugs only, excluding generics and label supplements.
SHREE HARI INTL's Therapeutic Areas
SHREE HARI INTL's approved drugs and pipeline span 1 therapeutic area, led by Immunology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SHREE HARI INTL's Top Competitors
SHREE HARI INTL's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SHREE HARI INTL Pipeline Snapshot
Active clinical trials for SHREE HARI INTL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1985-08-12
- Latest
- 2021-04-28
- Applications
- 3